Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

51

Actual shortage: 5 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 45 (88%)

Discontinuation Reports

7

To be discontinued: 0 (0%)
Discontinued: 4 (57%)
Reversed: 3 (43%)

Late reports

4 (7%)

Overdue reports

2 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPREFACT DEPOT 3 MONTHS 9.45MG IMPLANT Actual shortage 2024-07-11 2024-07-12 232667
VALCYTE 450MG TABLET Resolved 2023-05-02 2023-05-25 191490
VALCYTE 450MG TABLET Resolved 2023-09-27 2023-11-05 205325
VALCYTE 450MG TABLET Resolved 2024-01-04 2024-02-01 214848
VALCYTE 50MG POWDER FOR SOLUTION Resolved 2023-05-02 2023-11-05 191497
VEPESID 50MG CAPSULE Avoided shortage 2018-05-16 2018-12-20 49573
VEPESID 50MG CAPSULE Resolved 2018-12-20 2019-07-05 70228
VISUDYNE 15MG POWDER FOR SOLUTION Resolved 2020-08-31 2022-02-11 123386
VISUDYNE 15MG POWDER FOR SOLUTION Resolved 2022-07-20 2022-08-13 165082
VISUDYNE 15MG POWDER FOR SOLUTION Resolved 2024-01-04 2024-03-01 214845
XENICAL 120MG CAPSULE Resolved 2021-05-13 2021-08-10 139254

Showing 41 to 51 of 51

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANANDRON 50MG TABLET Reversed 2024-05-16 2024-07-10 228155
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
SUPREFACT DEPOT 2 MONTHS 6.3MG IMPLANT Reversed 2024-05-16 2024-06-19 228169
SUPREFACT DEPOT 3 MONTHS 9.45MG IMPLANT Reversed 2024-05-16 2024-07-10 228166
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 7 of 7